Founding of Livzon Pharmaceutical Development Co., Ltd.
The company name was changed to Zhuhai Special Economic Zone Livzon Pharmaceutical (Group) Co., Ltd.
The Livzon Group was restructured into a joint stock enterprise, and was named Zhuhai Special Economic Zone Livzon Pharmaceutical Group Inc.
The Livzon Group stock was listed on the A share and B share markets (in June); becoming the first pharmaceutical company in China to be listed on both the A and B share markets.
The company name was changed to Livzon Pharmaceutical Group Inc.
Joincare Pharmaceutical Group Industry Co. Ltd. became the biggest shareholder of Livzon Pharmaceutical Group.
The signing ceremony for the construction of the new Livzon Pharmaceutical Group plant was held in the Liangang Industrial Zone, Jinwan district, Zhuhai.
The groundbreaking ceremony for the first phase construction of the Livzon Pharmaceutical Group relocation project was held in the Liangang industrial Zone, Jinwan district, Zhuhai.
Mr. Zhu Baoguo, Livzon Pharmaceutical Group Chairman of the Board, was named one of the Top Ten Outstanding Economic Figures of Guangdong Province.
The Shenqi Fuzheng injection won the First Prize of the 2009 Guangdong Scientific & Technological Progress Award.
The Livzon Pharmaceutical Group was successfully listed on the Main Board of the Hong Kong Exchanges and Clearing Limited, which further extended the company’s solid steps toward modernization, standardization, and internationalization. Its standing on the Hong Kong Exchanges and Clearing Limited paved the way for the company to become a representative enterprise for internationalization in China.
Ilaprazole sodium won the first prize of 2013 Guangdong Scientific & Technological Progress Award. It was the second time that the Livzon Pharmaceutical Group won this honor, after its Shenqi Fuzheng injection was awarded the prize in 2009.
The Anti-Viral Granule won the first prize of the 2014 Scientific & Technological Award from the China Association of Traditional Chinese Medicine. The Anti-Viral Granule previously won the third prize of the 2013 Guangdong Scientific & Technological Award.
Ilaprazole won the second prize of the National Scientific & Technological Progress Award in conference that was held in Beijing.
Livzon Pharmaceutical Group relocated from Guihua North Road (Xiangzhou, Zhuhai) to the Livzon Industrial Park (Chuangye North Road, Jinwan, Zhuhai), covering an area of 427,000 square meters
Ilaprazole sodium for injection was approved for production.
Chairman Zhu Baoguo won the title of 2017 Pharmaceutical Economics Person of the Year.
The project “Research and Application of Triterpenoid Saponins in the Traditional Chinese Medicine and Natural Medicines” won second prize of the National Scientific & Technological Award.
Livzon Pharmaceutical Group won the honor of the Most Respectful Listed Company by investors.
The use of Chinese medicine composition in preparing Anti- EV71 (Human enterovirus 71) drugs, a patent of the Livzon Pharmaceutical Group, won the 19th Chinese Patent Award.